TriSalus Life Sciences, Inc. (TLSI) Stock Forecast
Data as of Aug 7, 2026Healthcare · Current price $5.67 (+16.53%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
TLSI vs Sector & Market
| Metric | TLSI | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.25 | 2.42 |
| Analyst Count | 3 | 8 | 18 |
| Target Upside | +76.8% | +16316.1% | +17.2% |
| P/E Ratio | -5.36 | 3.59 | 36.06 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $58M | $60M | $62M | 3 |
| 2027-03-31 | $18M | $19M | $19M | 1 |
| 2027-06-30 | $19M | $19M | $20M | 2 |
| 2027-09-30 | $18M | $19M | $19M | 2 |
| 2027-12-31 | $21M | $21M | $21M | 1 |
| 2028-03-31 | $25M | $26M | $26M | 1 |
| 2028-06-30 | $26M | $27M | $28M | 1 |
| 2028-09-30 | $29M | $29M | $30M | 1 |
| 2028-12-31 | $30M | $30M | $31M | 1 |
| 2029-12-31 | $142M | $146M | $152M | 2 |
| 2030-12-31 | $176M | $180M | $188M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $-0.40 | $-0.38 | $-0.36 | 2 |
| 2027-03-31 | $-0.06 | $-0.06 | $-0.06 | 1 |
| 2027-06-30 | $-0.03 | $-0.03 | $-0.03 | 1 |
| 2027-09-30 | $-0.03 | $-0.03 | $-0.03 | 1 |
| 2027-12-31 | $-0.01 | $-0.01 | $-0.01 | 1 |
| 2028-03-31 | $0.00 | $0.00 | $0.00 | 0 |
| 2028-06-30 | $0.00 | $0.00 | $0.00 | 0 |
| 2028-09-30 | $0.00 | $0.00 | $0.00 | 0 |
| 2028-12-31 | $0.00 | $0.00 | $0.00 | 0 |
| 2029-12-31 | $0.48 | $0.50 | $0.52 | 1 |
| 2030-12-31 | $1.07 | $1.10 | $1.16 | 1 |
Frequently Asked Questions
What is the analyst consensus for TLSI?
The consensus among 3 analysts covering TriSalus Life Sciences, Inc. (TLSI) is Buy with an average price target of $8.00.
What is the highest price target for TLSI?
The highest analyst price target for TLSI is $8.00.
What is the lowest price target for TLSI?
The lowest analyst price target for TLSI is $8.00.
How many analysts cover TLSI?
3 analysts have issued ratings for TriSalus Life Sciences, Inc. in the past 12 months.
Is TLSI a buy or sell right now?
Based on 3 analyst ratings, TLSI has a consensus rating of Buy (2.00/5) with a +76.8% upside to the consensus target of $8.00.
What are the earnings estimates for TLSI?
Analysts estimate TLSI will report EPS of $-0.38 for the period ending 2026-12-31, with revenue estimated at $60M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.